AMG 397
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 397, covering 2023-04-12 to 2023-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies [Phase 1]